Metastasis: A Therapeutic Target for Cancer

Patricia S Steeg; Dan Theodorescu

Disclosures

Nat Clin Pract Oncol. 2008;5(4):206-219. 

In This Article

Conclusions

It is time for agents that target metastasis and, in particular, metastatic colonization, to enter mainstream clinical development and testing. We hypothesize that the addition of these targets to the current armamentarium will ultimately enhance the efficacy of current treatment regimens. There is a lot of work remaining, including the selection of optimum drug combinations and the optimization of multiple aspects of trial design. In addition, we must garner the willpower to conduct adjuvant trials when fantastic objective response rates are not seen in the metastatic setting -- it can be done.


CLICK HERE for subscription information about this journal.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....